Research Interest

  • development of animal models to evaluate emerging infectious diseases and mitigation of disease in vulnerable populations
  • development of novel antibody assays for emerging viral infections
  • characterizing virus-specific antibody responses in lentivirus vaccination and infection 
  • defining mechanisms of antibody-mediated virus neutralization
  • defining the role of virus-specific B-cell responses in infection and disease progression


Kelly Stefano Cole, PhD

Director of Clinical Microbiology

 

  • : 412-359-8382

  • DEPARTMENTUniversity of Pittsburgh
  • COUNTRYUSA